IQVIA's Global Lead Talks Unlocking AI for Drug Repurposing

IQVIA's Global Lead Talks Unlocking AI for Drug Repurposing

In a conversation with Nathan Sommerford, HIT Consultant and Global Lead for medication Discovery and Development, IQVIA discusses how the potential of artificial intelligence (AI) in medication repurposing is reshaping the pharmaceutical and biotechnology industries. What are some of the difficulties and issues that come with "from scratch" drug discovery? IQVIA's Nathan Sommerford is the company's global lead for drug development. Developing a new drug and successfully bringing it to market can cost up to $1.8 billion and take ten years or more according to the conventional drug research and development paradigm, with the drug discovery and screening stages alone requiring up to four years. Traditional techniques frequently take the lead from the therapy field rather than the strength of the premise. 

Next Article

Did you find this useful?

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.

© 2024 Netspective Media LLC. All Rights Reserved.

Built on Jun 14, 2024 at 1:20pm